abstract |
The present invention discloses formulations of stabilized controlled release vitamin D compounds. The formulation comprises one or both of 25-hydroxyvitamin D 2 and 25-hydroxyvitamin D 3 , and a cellulosic compound. The stabilized formulation exhibits a stable dissolution profile after exposure to storage conditions and exhibits improved pharmacokinetic parameters as compared to unstabilized formulations. |